Диссертация (1139978), страница 34
Текст из файла (страница 34)
– p. 60 – 67.151. Nombela C. Genetic impact on cognition and brain function in newly diagnosedParkinson’s disease: ICICLE-PD study / Nombela C., Rowe J.B., Winder-RhodesS.E., Hampshire A., Owen A.M., Breen D.P., et al. //Brain. – 2014. – Vol. 137. –2743-58.152. Oertel W. Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson’s disease dementia: a retrospective analysis of a doubleblind trial and an open-label extension /142Oertel W., Poewe W., Wolters E., etal.
// Drug Saf. – 2008. –Vol.31. – p. 79-94.153. Оhara K.Changes of monoamines in post-mortembrains from patients with diffuse Lewy body disease /Ohara K., Kondo N. //Prog Neuropsychopharmacol.BiolPsychiatry. –1998. –Vol. 22. – р.311–7.193154. Otero J. L. Dementia with Parkinson’s disease Clinical diagnosis, neuropsychological aspects and treatment Dementia /Otero J.
L. // Neuropsychologia –2008 –December –2(4) – р.261-266155. Owen A.M. Cognitive dysfunction in Parkinson’s disease: the role of frontostriatalcircuitry/ Owen A.M. //Neuroscientist. – 2004. –Vol. 10. – p. 525-37.156. Pagonabarraga J.Cognitive impairment and dementia in Parkinson’s disease / Pagonabarraga J., Kulisevsky J. // Neurobiol Dis. – 2012. – Vol. 46. – p. 590-6.157. Pan P.
Gray matter atrophy in Parkinson’s disease with dementia: evidence frommeta-analysis of voxel-based morphometry studies / Pan P.L., Shi H.C., ZhongJ.G., Xiao P.R., Shen Y., Wu L.J., et al. //Neurol Sci. – 2013. – Vol. 34. – p. 61319.158. Paolo A.M. Differentiation of the dementias of Alzheimer's and Parkinson's disease with the dementia rating scale /Paolo A.M., Troster A.I., Glatt S.L., HubbleJ.P., Koller W.C. // J Geriatr Psychiatry Neurol. – 1995. – Vol. 8. –р.
184–188.159. Pedersen K.F. Occurrence and risk factors for apathy in Parkinson disease: a 4year prospective longitudinal study /Pedersen K.F., Alves G., Aarsland D., LarsenJ.P.// J Neurol Neurosurg Psychiatry. –2009 – Vol.80. – p. 1279–1282.160. Pereira J.B. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson’s disease /Pereira J.B., Junqué C., Martí M-J., RamirezRuiz B., Bargalló N., Tolosa E. // Mov Disord.
– 2009. – Vol. 24. – p. 1193-9.161. Perry E.K. Increased Alzheimer pathology in Parkinson’s disease related to antimuscarinic drugs /Perry E.K., Kilford L., Lees A.J., Burn D.J., Perry R.H.// AnnNeurol. – 2003 – Vol.54. – p. 235–238.162. Petersen S.E. The attention system of the human brain: 20 years after /PetersenS.E., Posner M.I. // Annu RevNeurosci . – 2012. – Vol. 35. – p. 73-89.163. Petrova M. Clinical and Neuropsychological Differences between Mild Parkinson's Disease Dementia and Dementia with Lewy Bodies / Petrova M., Mehrabian-Spasova S., Aarsland D.// Dementia And Geriatric Cognitive Disorders Extra[Dement Geriatr Cogn Dis Extra] –2015 –May 29 –Vol.
5 (2) – p. 212-20.194164. Piggott M.A. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson'sdiseases: rostrocaudal distribution / Piggott M.A., Marshall E.F., Thomas N., et al.// Brain. – 1999. –Vol. 122. – p.1449–68165. Pillon B.Explicit memory in Alzheimer's disease, Huntington's disease, and Parkinson's disease / Pillon B., Deweer B., Agid Y., Dubois B. // Arch Neurol. –1993.– Vol.
50 – p. 374–379.166. Pinto L, Goard M.J., Estandian D., Xu M., Kwan A.C., Lee S-H., et al. . Fastmodulation of visualperception by basal forebrain cholinergic neurons. / Pinto L,Goard M.J., Estandian D., Xu M., Kwan A.C., Lee S-H., et al. /Nat Neurosci. –2013.
– Vol. 16. – p. 1857-63.167. Poliako E. Orienting of attention andParkinson’s disease: tactile inhibition of return and responseinhibition /Poliako E., O’Boyle D.J., Moore A.P., McGloneF.P., Cody F.W.J., Spence C. // Brain . – 2003. – Vol.
126. – p. 2081-92.168. Ponsen M.M. three dimensional anatomicalview of oscillatory resting-state activity and functional connectivity in Parkinson’s disease relateddementia: an MEGstudy using atlas-based beamforming / Ponsen M.M., Stam C.J., BosboomJ.L.W., Berendse H.W., Hillebrand A. A //NeuroImage Clin . – 2012. –Vol.
2 – p.95-102.169. Ray M. Involvement of alpha6/alpha3neuronal nicotinic acetylcholine receptorsin neuropsychiatric features of dementia with Lewy bodies: [(125)I]-alphaconotoxin MII binding in the thalamus and striatum / Ray M., Bohr I., McIntoshJ.M., et al. 156Ray M., Bohr I., McIntosh J.M., et al. // Neurosci Lett. – 2004. –372. – р. 220–5.170. Reid W.G.J. Dementia in Parkinson’s disease: a 20-year neuropsychologicalstudy (Sydney Multicentre Study) / Reid W.G.J., Hely M.
A., Morris J. G. L.,LoyC., Halliday G. //J Neurol Neurosurg Psychiatry. – 2011. – Vol.82. – p. 1033.171. Richard I.H. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease / Richard I.H., McDermott M.P., Kurlan R., et al. //Neurology.
–2012. – Vol.78. – p. 1229-1236.195172. Ridha B.H. Delusion and hallucination indementia with Lewy bodies: worseningwith memantine / Ridha B.H., Josephs K.A., Rossor M.N. // Neurology. –2005. –Vol.65 – p. 481-482.173. Reitan, R. & Wolfson, D. The Halstead-Reitan Neuropsychological Test Battery /Reitan, R. & Wolfson, D./ – 1985.174. Rolinski M. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease /RolinskiM., Fox C, Maidment I., McShane R. // Cochrane Database Syst Rev – 2012. –Vol.3.
– CD006504.175. Roman G.C. Vasculardementia: diagnostic criteria forresearch stadies. Report ofNINDS-AIREN International Workshop. /Roman G.C.,Tatemichi T.K. et al.//Neurology. –1993 –Vol.43 –p.250-260176. Sampson T.R. Gut microbiota regulate motor deficit and neuroinflammation in amodel of Parkinson s disease/ Sampson T.R.,Debelius J.W., Thron T. et al// Cell– 2016 – Vol. 167. – №6 – p. 1469 – 1480.177. Santangelo G.A Neuropsychological longitudinal study in Parkinson’s patientswith and without hallucinations / Santangelo G., Trojano L., Vitale C., IannicielloM., Amboni M., Grossi D., et al. // Mov.
Disord Sampson T.R. 2007. – Vol. 22 –p. 2418-25.178. Sarter M. More attention must be paid: the neurobiology of attentionale effort /Sarter M., Gehring W.J., Kozak R. // Brain Res Rev. – 2006. – Vol. 51. – p. 14560.179. Schrag A.Young-onset Parkinson's disease revisited-clinical features, natural history, and mortality /Schrag A., Ben-Schlomo Y., Brown R, Marsden C.D., QuinnN // Mov Disord. – 1998. –Vol.13. –р.
885–894.180. Selikhova M. A clinicopathological study of subtypes in Parkinson’s disease / Selikhova M., Williams D.R., Kempster P.A., et al. A // – Brain. – 2009. – Vol.132.– р. 2947–2957.196181.LeеSeung-Hwan Brain volumetry in Parkinson’s disease with and without dementia: where are the differences? / Seung-Hwan Leе, Sam Soo Kim, Woo-SukTae, Seo-Young Lee, Kang Uk Lee // Acta Radiol . – 2013. – Vol.54. – р. 581 -7182. Shibata M. Cardiac parasympathetic dysfunction concurrent withcardiac sympathetic denervation in Parkinson’s disease / Shibata M., Morita Y., Shimizu T.,Takanashi K. // J Neurol Sci.
– 2009. –Vol.276. –р. 79–83.183. Shimada H. Mapping of brainacetylcholinesterase alterations in Lewy body disease by PET / Shimada H., Hirano S., Shinotoh H., Aotsuka A., Sato K., TanakaN., et al. .// Neurology. – 2009. –Vol.. 73. – p. 273-8.184. Shin S. Neuroanatomical substrates of visual hallucinations in patients with nondemented Parkinson’s disease / Shin S., Lee J.E., Hong J.Y., Sunwoo M-K., SohnY.H., Lee P.H. //J. Neurol Neurosurg Psychiatry.
– 2012. –Vol.. 83. – p. 1155-61.185. Sinforiani E. Cognitive rehabilitation in Parkinson’s disease / Sinforiani E.,Banchieri L., Zucchella C., Pacchetti C., Sandrini G. //Arch Gerontol GeriatrSuppl. – 2004. – p. 387-91.186. Song S.K. The pattern of cortical atrophy in patients with Parkinson’s disease according to cognitive status / Song S.K., Lee J.E., Park H-J, Sohn Y.H, Lee J.D.,Lee P.H.// Mov Disord . – 2011. – Vol. 26 – p.
289-96.187. Soma S.Modulation-specific and laminar-dependent effects of acetylcholine onvisual responses in the rat primary visual cortex / Soma S., Shimegi S., SuematsuN., Tamura H., Sato H. // PLoS One . – 2013. –Vol.. 8. – p. 68430.188. Stam C.J. Disturbed frontal regulation of attention in Parkinson’s disease / StamC.J., Visser S.L., Op de Coul A.A., De Sonneville L.M., Schellens R.L., BruniaC.H., et al. // Brain. – 1993. –Vol.116.
– Pt 5. – p. 1139-58.189. Starkstein S.E. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia / Starkstein S.E., Sabe L.,Petracca G., et al. // J Neurol Neurosurg Psychiatry. –1996. – Vol.61. – р.381 –387.190.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
